These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 5663311)
21. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia]. Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028 [No Abstract] [Full Text] [Related]
22. [Treatment of dyslipemias with the association of dx-thyroxine and choleretics]. Martinelli M; Albini U; Villecco A Boll Soc Ital Cardiol; 1970; 15(6):539-43. PubMed ID: 5517650 [No Abstract] [Full Text] [Related]
23. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids. Best MM; Duncan CH Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616 [No Abstract] [Full Text] [Related]
24. Drug treatment of hyperlipidemia. Berkowitz D Mod Treat; 1969 Nov; 6(6):1341-51. PubMed ID: 5377637 [No Abstract] [Full Text] [Related]
26. [Effects of clofibrate in the treatment of hyperlipidemia. (Apropos of 61 cases)]. Warembourg H; Jaillard J Rev Atheroscler (Paris); 1966; 8(1):53-5. PubMed ID: 5961028 [No Abstract] [Full Text] [Related]
27. Diet and drugs in the treatment of hyperlipidemias. Med Lett Drugs Ther; 1970 May; 12(10):42-4. PubMed ID: 5514225 [No Abstract] [Full Text] [Related]
28. [Importance of the clofibrat in the treatment of lipid metabolism disorders]. Laubinger G Med Klin; 1968 Jan; 63(4):139-42. PubMed ID: 5670163 [No Abstract] [Full Text] [Related]
29. Clofibrate in perspective. N Engl J Med; 1968 Oct; 279(16):885-6. PubMed ID: 5677725 [No Abstract] [Full Text] [Related]
30. The use of pharmacologic agents in atherosclerosis therapy. Kritchevsky D Ann N Y Acad Sci; 1968 Nov; 149(2):1058-68. PubMed ID: 4890515 [No Abstract] [Full Text] [Related]
31. [Atherosclerosis and Regelan]. Schwaar R Praxis; 1966 Aug; 55(31):875-80. PubMed ID: 5953569 [No Abstract] [Full Text] [Related]
33. [The effect of Atromid treatment of patients with essential hyperlipidemia and xanthomatosis]. Baranova LV Ter Arkh; 1967 Jul; 39(7):61-3. PubMed ID: 5610932 [No Abstract] [Full Text] [Related]
34. Drug treatment of hyperlipidemia. Yeshurun D; Gotto AM Am J Med; 1976 Mar; 60(3):379-96. PubMed ID: 1258886 [TBL] [Abstract][Full Text] [Related]
35. The coronary drug project. Design, methods, and baseline results. Circulation; 1973 Mar; 47(3 Suppl):I1-50. PubMed ID: 4570454 [No Abstract] [Full Text] [Related]
36. [Progress on a new form of treatment of lipoarteriosis]. Vargas LE; Velasco JR Rev Esp Cardiol; 1972; 25(3):239-46. PubMed ID: 5069029 [No Abstract] [Full Text] [Related]
37. [Hyperlipidemias: occurrence, significance, therapy]. Knüchel F Med Welt; 1967 Aug; 32():1848-60. PubMed ID: 5589916 [No Abstract] [Full Text] [Related]
38. [Action of ethyl chlorophenoxyisobutyrate on several types of hyperlipidemia]. Beaumont V; Swynghedauw B; Beaumont JL; Himbert J Rev Atheroscler (Paris); 1966; 8(1):12-20. PubMed ID: 5961026 [No Abstract] [Full Text] [Related]
39. [Drug therapy of hyperlipemia. Role of drugs at the disposition of general practitioners]. Pometta D Ther Umsch; 1970 Mar; 27(3):128-32. PubMed ID: 5437609 [No Abstract] [Full Text] [Related]
40. Physiological rationale for differential drug therapy. Levy RI Postgrad Med J; 1975; 51(8):60-2. PubMed ID: 1221380 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]